PRESS RELEASE published on 09/05/2024 at 11:11, 2 months 16 days ago Elis: Disclosure of the number of shares forming the capital and of the total number of voting rights as of 31 08 2024 Disclosure of the number of shares forming the capital and voting rights as of 31 August 2024 by Elis SA. Details on www.elis.com Voting Rights Shares Investor Relations Financial Disclosure Elis SA
BRIEF published on 09/03/2024 at 08:55, 2 months 18 days ago Elis launches the employee shareholding operation "Elis for All" 2024 Capital Increase Employee Shareholding Elis "Elis For All" Discount And Additional Payment
BRIEF published on 08/27/2024 at 12:18, 2 months 25 days ago Elis: Declaration of the Number of Shares and Voting Rights as of July 31, 2024 Share Capital Voting Rights Actions Financial Statement Elis
PRESS RELEASE published on 08/27/2024 at 12:13, 2 months 25 days ago Disclosure of the number of shares forming the capital and of the total number of voting rights as of 31 07 2024 Disclosure of the number of shares and voting rights for Elis SA as of 31 July 2024, in accordance with legal requirements. For more details visit www.elis.com Voting Rights Shares Investor Relations Disclosure Elis SA
BRIEF published on 07/25/2024 at 15:31, 3 months 26 days ago Elis: Half-yearly review of the liquidity contract as of June 30, 2024 Liquidity Contract Transactions ODDO BHF 2024 Elis
PRESS RELEASE published on 07/25/2024 at 15:26, 3 months 26 days ago Elis: Half-yearly report relative to the liquidity contract as of 30 June 2024 Elis releases half-yearly liquidity contract report with Oddo BHF (Group Natixis) showing 168,261 shares and €1,569,894 on June 30, 2024. Previous activity and terminations noted Liquidity Contract Shares ODDO BHF Report Elis
BRIEF published on 07/25/2024 at 11:55, 3 months 27 days ago Elis makes its 2024 half-year financial report available AMF Financial Report Consolidated Accounts Elis Semester 2024
PRESS RELEASE published on 07/25/2024 at 11:50, 3 months 27 days ago Elis announces the availability of its 2024 half-year financial report Elis releases 2024 half-year financial report with activity, results & financial statements. Available for free on website & AMF. Contacts for Investor Relations Investor Relations Financial Report 2024 French AMF Elis
BRIEF published on 05/27/2024 at 11:25, 5 months 25 days ago Elis: Adjustment to the Conversion Ratio (OCEANE 2029) Dividend Shareholders' Meeting Elis OCEANE 2029 Conversion Ratio
PRESS RELEASE published on 05/27/2024 at 11:20, 5 months 25 days ago Elis: Adjustment to the conversion ratio (OCEANE 2029) Elis adjusts conversion/exchange ratio for OCEANE 2029 bonds in accordance with terms. Conversion now 6,028.1002 ordinary shares for 1 OCEANE from May 29, 2024 Shareholders Meeting Elis OCEANE 2029 Conversion Ratio Adjustment
Published on 11/21/2024 at 13:00, 34 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 34 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 34 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 34 minutes ago Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 34 minutes ago Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension
Published on 11/21/2024 at 12:35, 58 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 18 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 36 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 13 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 49 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 49 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
